Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.56 |
| ▸ | POLB | P06746 | 3/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.56 |
| ▸ | TP53 | P04637 | 1/20 | 0.56 |
| ▸ | GLA | P06280 | 1/20 | 0.56 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.56 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.56 |
| ▸ | HPGD | P15428 | 1/20 | 0.56 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.56 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.56 |
| ▸ | APEX1 | P27695 | 1/20 | 0.56 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.56 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.56 |
| ▸ | GAA | P10253 | 2/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | DNMT1 | P26358 | 1/20 | 0.43 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.42 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2992788 | 0.88 | POLB (0.73) | ALDH1A1POLBKDM4ETP53GLA | |
| SCHEMBL2992785 | 0.88 | ALDH1A1 (0.73) | ALDH1A1POLBKDM4ETP53GLA | |
| SCHEMBL1756998 | 0.85 | ALDH1A1 (0.49) | ALDH1A1POLBKDM4ETP53GLA | |
| SCHEMBL9899716 | 0.84 | ALDH1A1 (0.50) | ALDH1A1POLBKDM4ETP53GLA | |
| SCHEMBL5958908 | 0.81 | ALDH1A1 (0.55) | ALDH1A1POLBKDM4ETP53GLA | |
| SCHEMBL29453019 | 0.81 | ALDH1A1 (0.48) | ALDH1A1POLBKDM4ETP53GLA | |
| SCHEMBL21635 | 0.81 | ALDH1A1 (0.48) | ALDH1A1POLBKDM4ETP53GLA | |
| SCHEMBL3195963 | 0.81 | ALDH1A1 (0.48) | ALDH1A1POLBKDM4ETP53GLA | |
| SCHEMBL2989623 | 0.80 | ALDH1A1 (0.50) | ALDH1A1POLBKDM4ETP53GLA | |
| SCHEMBL9898512 | 0.80 | ALDH1A1 (0.47) | ALDH1A1POLBKDM4ETP53GLA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090275630-A1 | COSMETIC COMPOSITION COMPRISING AN IMIDOPERCARBOXYLIC ACID DERIVATIVE AND A N-ACYLATED AMINO ACID ESTER | L'OREAL (FR) | 2009-11-05 | — | — | US | claimed |
| US-7468387-B2 | Crystalline forms of imidoalkanpercarboxylic acids | SOLVAY SOLEXIS S.P.A. (IT) | 2008-12-23 | — | — | US | claimed |
| EP-1130014-B1 | Process for the purification of imidoalkanpercarboxylic acids | SOLVAY SOLEXIS SPA (IT) | 2006-06-14 | — | — | EP | claimed |
| JP-2005538978-A | — | — | 2005-12-22 | — | — | JP | claimed |
| US-20050245590-A1 | Crystalline forms of imidoalkanpercarboxylic acids | SOLVAY SOLEXIS S.P.A (IT) | 2005-11-03 | — | — | US | claimed |
| EP-1523474-A1 | CRYSTALLINE FORMS OF IMIDOALKANPERCARBOXYLIC ACIDS | Solvay Solexis S.p.A. (IT) | 2005-04-20 | — | — | EP | claimed |
| WO-2004007452-A1 | CRYSTALLINE FORMS OF IMIDOALKANPERCARBOXYLIC ACIDS | SOLVAY SOLEXIS S.P.A. (IT) | 2004-01-22 | — | — | WO | claimed |
| EP-0780374-B1 | Process for reducing water and polar impurities in imido-alkanpercarboxylic acids | AUSIMONT SPA (IT) | 2002-04-03 | — | — | EP | claimed |
| EP-1130014-A2 | Process for the purification of imidoalkanpercarboxylic acids | Ausimont S.p.A. (IT) | 2001-09-05 | — | — | EP | claimed |
| US-5703245-A | HEATING SUSPENSION OF IMIDO ACIDS TO MELTING, SEPARATION OF ORGANIC PHASE | AUSIMONT, S.P.A. (IT) | 1997-12-30 | — | — | US | claimed |
| EP-0780374-A1 | Process for reducing water and polar impurities in imido-alkanpercarboxylic acids | AUSIMONT S.p.A. (IT) | 1997-06-25 | — | — | EP | claimed |
| EP-0325288-B1 | IMIDO-AROMATIC PERCARBOXYLIC ACIDS | AUSIMONT S.p.A. (IT) | 1993-09-01 | — | — | EP | claimed |
| EP-0325289-B1 | BLEACHING AGENTS COMPRISING IMIDO-AROMATIC PERCARBOXYLIC ACIDS | AUSIMONT S.p.A. (IT) | 1993-09-01 | — | — | EP | claimed |
| EP-0325289-A1 | Bleaching agents comprising imido-aromatic percarboxylic acids | AUSIMONT S.p.A. (IT) | 1989-07-26 | — | — | EP | claimed |
| EP-4263779-A1 | A LAUNDRY TREATMENT COMPOSITION | Unilever IP Holdings B.V. (NL) | 2023-10-25 | — | — | EP | disclosed |
| WO-2022136270-A1 | A LAUNDRY TREATMENT COMPOSITION | UNILEVER IP HOLDINGS B.V. (NL) | 2022-06-30 | — | — | WO | disclosed |
| WO-2020060434-A1 | BREAKER COMPOSITION FOR OIL FRACKING | SOLVAY SA (BE) | 2020-03-26 | — | — | WO | disclosed |
| EP-0325288-B1 | IMIDO-AROMATIC PERCARBOXYLIC ACIDS | AUSIMONT S.p.A. (IT) | 1993-09-01 | — | — | EP | disclosed |
| EP-0325289-A1 | Bleaching agents comprising imido-aromatic percarboxylic acids | AUSIMONT S.p.A. (IT) | 1989-07-26 | — | — | EP | disclosed |
| EP-0325288-A1 | Imido-aromatic percarboxylic acids | AUSIMONT S.p.A. (IT) | 1989-07-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050245590-A1 | Crystalline forms of imidoalkanpercarboxylic acids | UACA, CA1, SLC25A1 | ALDH1A1 1199/4885POLB 1990/4885KDM4E 4671/4885 |
| US-20090275630-A1 | COSMETIC COMPOSITION COMPRISING AN IMIDOPERCARBOXYLIC ACID DERIVATIVE AND A N-ACYLATED AMINO ACID ESTER | DDC, ALAD, AADAC | ALDH1A1 407/4885POLB 3271/4885KDM4E 2132/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.